Selected
Type of publications
Regions
Countries
Diseases
Publication date
Target population
Available to download in languages
259 results found
2023 ∙ Guo, Jianming Guo, Shuyan Dong, Siping
Efficacy, immunogenicity and safety of HPV vaccination in Chinese population: A meta-analysis
  • Efficacy/effectiveness
  • Safety
  • Adolescents
  • Adults
  • China
  • Human papillomavirus (HPV)
Rating:
Critically low
2023 ∙ Middleton, Bianca F. Danchin, Margie Fathima, Parveen Bines, Julie E. Macartney, Kristine Snelling, Thomas L.
Review of the health impact of the oral rotavirus vaccine program in children under 5 years in Australia: 2006 - 2021
  • Coverage
  • Efficacy/effectiveness
  • Safety
  • Newborn
  • Children
  • Australia
  • Rotavirus
Rating:
Critically low
2023 ∙ Ahmad, Hanis Sanef, Siti Aishah Shahabudin, Winda Zulaiha Mohtar, Norfaqihah Hassan, Mohd Rohaizat Jeffree, Mohammad Saffree Lukman, Khamisah Awang Ghazi, Hasanain Faisal Syed Abdul Rahim, Syed Sharizman
Socioecological Challenges of Polio Supplementary Immunization Activities (SIAs) in the Asia-Pacific Region: A Systematic Review
  • Coverage
  • Acceptance
  • All age groups
  • Parents/caregivers
  • Healthcare workers
  • Poliomyelitis
Rating:
Not applicable
2023 ∙ Garg, R. K. Paliwal, V. Malhotra, H. S. Singh, B. P. Rizvi, I. Kumar, N.
Spectrum of Serious Neurological and Psychiatric Adverse Events in Indian COVID-19 Vaccine Recipients: A Systematic Review of Case Reports and Case Series
  • Vaccine/vaccination
  • Safety
  • Adults
  • Older adults
  • India
  • COVID-19
Rating:
Critically low
2023 ∙ Wang, Qiang Yang, Liuqing Li, Lan Liu, Chang Jin, Hui Lin, Leesa
Willingness to Vaccinate Against Herpes Zoster and Its Associated Factors Across WHO Regions: Global Systematic Review and Meta-Analysis
  • Acceptance
  • Adults
  • Older adults
  • Herpes zoster
Rating:
Not applicable
2023 ∙ ATAGI
ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines
  • Recommendation
  • Australia
  • COVID-19
Download:
2023 ∙ ATAGI
ATAGI Update on the COVID-19 Vaccination Program
  • Recommendation
  • Australia
  • COVID-19
Download:
2023 ∙ ATAGI
ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older
  • Recommendation
  • Australia
  • COVID-19
Download:
2023 ∙ ATAGI
ATAGI advice on seasonal influenza vaccines in 2023
  • Recommendation
  • Australia
  • Influenza
Download:
2023 ∙ ATAGI
ATAGI 2023 booster advice
  • booster dose
  • Recommendation
  • Australia
  • COVID-19
Download: